Clinical Trials on HER-2 Positive Breast Cancer in Switzerland
Total 194 results
-
OnkoZentrum Zürich AGUniversity of Zurich; Palleos Healthcare GmbHCompletedHER2-positive Breast Cancer | Biosimilar | Patient Reported OutcomeSwitzerland
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug...SuspendedHER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast CancerKorea, Republic of, France, Israel, Belgium, Switzerland, Australia
-
AstraZenecaActive, not recruitingER-Positive HER2-Negative Breast CancerAustria, Belgium, France, Germany, Italy, United Kingdom, United States, Canada, India, Taiwan, Russian Federation, Korea, Republic of, Hungary, Japan, Mexico, Turkey, China, Malaysia, Spain, Czechia, Portugal, Poland, Norway, Bulgaria, Slovaki... and more
-
ETOP IBCSG Partners FoundationPfizer; Hoffmann-La RocheCompletedBreast Cancer | HER2-positive Breast Cancer | Estrogen Receptor Positive TumorFrance, Switzerland, Belgium, Italy
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
Prof. Wolfgang JanniEli Lilly and CompanyRecruitingHormone Receptor-positive Metastatic Breast Cancer | HER2-negative Metastatic Breast CancerGermany, Switzerland
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingHER2 Positive Breast CancerUnited States, Taiwan, Canada, Korea, Republic of, Austria, China, Spain, Japan, France, Italy, Switzerland, Australia, Belgium, Brazil, Germany, Portugal, United Kingdom, Netherlands, Czechia, Greece, Chile, Finland, Poland
-
Seagen Inc.RecruitingHER2-positive Breast CancerUnited States, Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Singapore, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
Seagen Inc.CompletedHER2 Positive Breast CancerUnited States, Spain, Belgium, Germany, Israel, France, United Kingdom, Austria, Denmark, Italy, Australia, Canada, Czechia, Portugal, Switzerland
-
North Eastern German Society of Gynaecological...Center for Clinical Trials Philipps University MarburgActive, not recruitingEstrogen Receptor Positive Tumor | Primary Invasive Breast Cancer | Human Epidermal Growth Factor Receptor 2 Negative TumorGermany, Switzerland
-
University Hospital, Basel, SwitzerlandETOP IBCSG Partners Foundation; Austrian Breast Cancer Study GroupRecruitingNode-positive Breast CancerGreece, Switzerland, Hungary, Austria, Germany, Italy, Lithuania, Argentina, Croatia
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia... and other collaboratorsActive, not recruitingRecurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States, Canada, Switzerland
-
Vincent Vinh-HungVarian Medical SystemsActive, not recruitingBreast Cancer FemaleSwitzerland
-
Lindenhofgruppe AGUniversity of Bern; StiftungLindenhofTerminatedBreast Cancer FemaleSwitzerland
-
Manuela EicherSwiss Cancer League; Lindenhofgruppe AGCompletedBreast Neoplasm | Self-Management | Intervention | Cancer Survivorship | Early-Stage Breast CancerSwitzerland
-
Centre Hospitalier Universitaire VaudoisRecruitingTriple Negative Breast CancerSwitzerland
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingMetastatic Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerAustria, Belgium, Italy, Spain, France, Switzerland, Denmark, Norway, Sweden
-
Brust-Zentrum AGCompleted
-
German Breast GroupGilead Sciences; ETOP IBCSG Partners Foundation; UNICANCER; Austrian Breast & Colorectal... and other collaboratorsActive, not recruitingTriple Negative Breast Cancer | HER2-negative Breast CancerFrance, Spain, Germany, Switzerland, Austria, Ireland, Belgium
-
Centre Hospitalier Universitaire VaudoisTerminatedBreast Cancer | Lung CancerSwitzerland
-
Swiss Federal Institute of TechnologyKantonsspital BadenCompletedBreast CancerSwitzerland
-
University of ZurichTerminated
-
Aline ReinmannCompletedCancer, Breast | Cancer, GynecologicSwitzerland
-
Kantonsspital Winterthur KSWTerminatedBreast Cancer, Invasive DuctalSwitzerland
-
Ente Ospedaliero Cantonale, BellinzonaPolitecnico di Milano; Clinical Trial Unit Ente Ospedaliero CantonaleCompleted
-
Palleos Healthcare GmbHmobile Health AGRecruiting
-
Swiss Group for Clinical Cancer ResearchNot yet recruitingTriple-negative Breast Cancer | TNBC - Triple-Negative Breast CancerSwitzerland
-
Christian SchweglerRecruitingChemotherapy Effect | Breast Cancer FemaleSwitzerland
-
European Organisation for Research and Treatment...CompletedBreast CancerSwitzerland
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Clinica Luganese MoncuccoSwiss National Science Foundation; Curzio Rüegg, MD, Head of Department, University... and other collaboratorsCompletedBreast CancerSwitzerland
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Puma Biotechnology, Inc.CompletedHER2+ Metastatic Breast Cancer (MBC)United States, Canada, Spain, Singapore, Korea, Republic of, Taiwan, United Kingdom, Israel, Australia, Japan, Hong Kong, Finland, Ireland, Italy, France, Portugal, Germany, Sweden, Belgium, Brazil, Czechia, Switzerland, Argentina, Au... and more
-
University Hospital, Basel, SwitzerlandCompletedBreast CancerSwitzerland
-
Oncology Institute of Southern SwitzerlandRecruiting
-
Centre Hospitalier Universitaire VaudoisUnknown
-
Gilead SciencesMerck Sharp & Dohme LLCRecruitingTriple Negative Breast Cancer | PD-L1 PositiveUnited States, Taiwan, Belgium, Australia, Austria, Israel, Spain, Italy, Korea, Republic of, Japan, France, Netherlands, Canada, Turkey, Germany, Malaysia, Singapore, United Kingdom, Hong Kong, Hungary, Mexico, Switzerland, Puerto... and more
-
Swiss Group for Clinical Cancer ResearchCompletedBreast CancerSwitzerland
-
University Hospital, Basel, SwitzerlandSana Kliniken Düsseldorf GmbHRecruitingBreast Cancer | LymphedemaSwitzerland
-
University Hospital Inselspital, BerneCompletedBreast CancerSwitzerland
-
Novartis PharmaceuticalsRecruiting
-
Plastic Surgery Group AG by Prof. Jian FarhadiCompletedBreast CancerSwitzerland
-
University of ZurichRecruitingBreast Cancer | ImplantsSwitzerland
-
University of ZurichUnknownBreast Cancer | Metastatic Neoplasm | ERBB2Switzerland
-
West German Study GroupAgendiaCompletedBreast CancerSwitzerland, Austria, Germany
-
Constanze ElfgenRecruiting
-
Life Molecular Imaging SACompletedDiagnostic ImagingNetherlands, Switzerland
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.Active, not recruitingBreast Cancer Metastatic | BRCA 1 Gene Mutation | BRCA 2 Gene MutationItaly, Spain, United States, Czechia, Romania, France, Korea, Republic of, United Kingdom, Hungary, Japan, Peru, Poland, Russian Federation, Turkey, China, Taiwan, Bulgaria, Switzerland, Mexico
-
CairnSurgical, Inc.CompletedBreast CancerItaly, Germany, Switzerland